HLB Life Science Co., Ltd. (067630.KQ) KOE
3,820.00
-5(-0.13%)
Currency In KRW
- General
- Statistics
- Historical Data
- Profile
- Financials
3,820.00
-5(-0.13%)
Currency In KRW
| Market Cap | 472.43B |
| Enterprise Value | 619.49B |
| P/E Ratio | -4.67 |
| PEG Ratio | -0.11 |
| Price/Sales Ratio | 7.3 |
| Price/Book Ratio | 1.57 |
| Enterprise/Revenue | 9.6 |
| Enterprise/EBITDA | -10.49 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | -1.56 |
| Operating Margin | -0.34 |
| Return On Assets | -0.21 |
| Return On Equity | -0.32 |
| Revenue | 45.75B |
| Revenue/Share | 523.23 |
| Gross Profit | -2.04B |
| EBITDA | -15.84B |
| Net Income | -99.85B |
| Diluted EPS | -818.99 |
| Total Cash | 13.34B |
| Total Cash/Share | 109.43 |
| Total Debt | 160.36B |
| Total Debt/Equity | 0.54 |
| Current Ratio | 0.58 |
| Book Value Per Share | 2,442.17 |
| 52-Week Change | -43.41 |
| 52-Week High | 6,800 |
| 52-Week Low | 3,105 |
| Moving Average 50 Days | 4,046.9 |
| Moving Average 200 Days | 4,175.6 |
| Average Volume | 517,616 |
| Shares Outstanding | 121.85M |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 525849:500000 |
| Last Split Date | December 28, 2022 |